Background. Although routine laryngeal examination (RLE) after thyroidectomy may cost more than selective laryngeal examination (SLE), it permits earlier detection and treatment of vocal cord palsy (VCP) and so may be cost-saving in the longer term. We compared the 2-year cost-effectiveness between RLE and SLE with RLE performed at 2 weeks (SLE-2w), 1 month (SLE-1m), and 3 months (SLE-3m) after thyroidectomy in the institution's perspective. Methods. Our case definition was a hypothetical 50-yearold woman who underwent an elective total thyroidectomy for a benign multinodular goiter. A decision-analytic model was constructed to compare the estimated cost-effectiveness between RLE, SLE-2w, SLE-1m, and SLE-3m after a 2-year period. Outcome probabilities, utilities, and costs were estimated from the literature. The threshold for costeffectiveness was set at US$50,000/quality-adjusted lifeyear. Sensitivity and threshold analyses were used to examine model uncertainty. Results. RLE was not cost-effective because its incremental cost-effectiveness ratio to SLE-2w, SLE-1m, and SLE-3m were US$302,755, US$227,883 and US$247,105, respectively. RLE was only cost-effective when the temporary VCP rate increased [42.7 % or when the cost of RLE equaled zero. Similarly, SLE-2w was only costeffective to SLE-3m when dysphonia for temporary VCP at 3 months increased [39.13 %, dysphonia for permanent VCP at 3 months increased [50.29 %, or dysphonia without VCP at 3 months increased [42.69 %. However, none of these scenarios appeared clinically likely. Conclusions. In the institution's perspective, RLE was not cost-effective against the other three SLE strategies. Regarding to the optimal timing of SLE, SLE-3m appears to be a reasonable and acceptable strategy because of its relative low overall cost.
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Thyroidectomy is one of the most commonly performed surgical procedures, and because postoperative vocal cord paresis or palsy (VCP) is an important procedural-related complication, information on the patient's postoperative vocal cord status is essential. [1] [2] [3] [4] However, postoperative routine laryngeal examination (RLE) of the vocal cords remains controversial. [1] [2] [3] [4] Although most surgeons would perform selective laryngeal examination (SLE) (i.e., laryngeal examination [LE] when voice symptoms/dysphonia have become persistent for some time after thyroidectomy), some prefer RLE. [5] [6] [7] [8] A large audit found that the frequency of postoperative LE ranges 0 to 100 %. 8 One reason for such divided practice is the issue of costeffectiveness in RLE, which has never been demonstrated. [1] [2] [3] [4] Although RLE would cost more than SLE because more LE are performed, recent studies have found that RLE permits earlier diagnosis and treatment of VCP (such as injection thyroplasty [IT] ) and so may be cost saving in the longer term. [9] [10] [11] [12] Furthermore, unlike SLE, RLE greatly shortens the duration of dysphonia, minimizing the loss of patient quality of life (QOL) (i.e., more effective). 9, 13 Therefore, RLE may prove more cost-effective than SLE in the long term. The other issue is related to the timing of the SLE strategy; this could range between 2 weeks and 3 months from thyroidectomy. [1] [2] [3] [4] 9 Although an early LE would lead to an earlier diagnosis and treatment of VCP, it may increase the detection and treatment of VCP, which are mostly temporary and fully recoverable without treatment. 5, 14 On the basis of these arguments, a decision tree analysis model was constructed to examine whether RLE was cost-effective to SLE over a medium term and also to find the optimal cost-effective timing for an SLE strategy.
MATERIALS AND METHODS
A decision tree model was constructed by TreeAge Software Pro version 2013 (TreeAge Software Inc., Williamstown, MA) to compare the 2-year estimated costeffectiveness between two main strategies, RLE and SLE, after elective total thyroidectomy. Under the RLE strategy, all postoperative patients were subjected to LE within 1-2 days after operation, regardless of their voice quality or symptoms. As a result, the cause of dysphonia was made early, which led to early IT (for those with dysphonia and 
FIG. 1 Decision-analytic modeling
Routine Examination is not Cost-EffectiveVCP) or speech therapy (for those with dysphonia but no VCP). In contrast, under the SLE strategy, only a select group of patients with persistent voice complaints or dysphonia for a period of time would undergo LE. As a result, the cause of dysphonia was not made until LE was performed after a period of dysphonia, which varied between 2 weeks and 3 months. [1] [2] [3] [4] 9 Because dysphonia rate and temporary VCP would decrease over time, the SLE was further divided into 3 substrategies to account for these time-related changes. They were SLE at 2 weeks (SLE2w), 1 month (SLE-1m), and 3 months (SLE-3m) after thyroidectomy. Therefore, our model comprised four strategies: RLE, SLE-2w, SLE-1m, and SLE-3m. Figure 1 outlines the decision-analytic modeling.
Base-Case Patient
A 50-year-old woman underwent an elective total thyroidectomy for a moderately enlarged but nonretrosternal benign multinodular goiter. She did not have any preoperative voice symptoms or VCP. In addition, she had not undergone any previous head and neck surgery or irradiation. Both recurrent laryngeal nerves were clearly visualized and appeared intact at the end of thyroidectomy.
Data Sources
Estimates of temporary and permanent VCP after total thyroidectomy were derived from pooling results of a recent systematic review and two recent large thyroid surgery registries. 8, 15, 16 The total number of patients pooled was 47,564. VCP rates were calculated on the basis of number of patients rather than nerves at risk. Other probabilities of outcomes, such as rates of postoperative dysphonia with and without VCP, recovery rate of temporary VCP, and chance of permanent vocal cord medialization with and without IT at 2 weeks, 1 month, and 3 months, were derived from a comprehensive PubMed search using free text search terms in ''All fields.'' These search terms included ''dysphonia,'' ''vocal cord palsy,'' ''injection thyroplasty,'' and ''vocal cord medialization.'' There were no language restrictions or methodological filters. The resulting bibliography of a recent clinical practice guideline on voice outcomes after surgery was also searched for additional relevant references. 9 Critical appraisal of each study was performed by two authors (BHL, CKW). Expert opinion was sought from two specialist otolaryngologists (RYT, BYW) if the outcome probabilities were not available in the literature. The range obtained from the experts was used to guide the sensitivity analysis if it was a more reliable source of information. Base-case values were derived by pooling the results of all retrieved studies. If only one study was available, the midpoint of the reported range was taken. Table 1 summarizes outcome probabilities.
Utilities
Effectiveness was measured by quality-adjusted lifeyears (QALY) gained. QALY adjusts the life expectancy through the multiplication of QOL adjustment with length of duration at each health state. The QOL adjustment is quantified by a utility score that typically ranges from 0 (death) to 1 (full health). Table 2 lists the utility score for each health state. In the present study, utilities were used as weights to calculate quality-adjusted life expectancy. A utility of 1.0 was assigned for a patient that underwent elective total thyroidectomy without dysphonia; 0.81 was assigned to any health state with the outcome of dysphonia after thyroidectomy, regardless of cause. 13 
Study Design and Decision Models
The analysis was designed from an institution's perspective using QALY as the overall outcome measure. For each strategy, QALY was the sum of two components: the time period the patient stayed in full health (i.e., without dysphonia) multiplied by 1.0, and the time of dysphonia multiplied by the utility score of 0.81 within a 2-year period.
Cost Data
Our model only looked at the cost of four strategies (RLE, SLE-2w, SLE-1m, and SLE-3m) from an institution's perspective. Total cost included procedural cost and complication cost. Indirect costs, such as loss of productivity and wages, were not included. Unit costs of LE, speech therapy, office-based IT, and vocal cord medialization under general anesthesia were estimated according to Medicare reimbursement for surgical procedure obtained from public access files from the Centers for Medicare and Medicaid Services and from data obtained from previous cost-effectiveness analyses. [17] [18] [19] [20] Table 3 summarizes the unit costs.
Assumptions
All LE were performed by expert otolaryngologists using standard techniques without complications or discomfort. All VCP were assumed to be unilateral only because bilateral would not have been clinically silent. Patients with asymptomatic VCP were assumed to have a utility score of 1 (i.e., the state of a healthy individual without VCP). For patients with symptomatic VCP confirmed on LE, IT was provided without delay, while those with dysphonia without VCP were provided with speech therapy. A single IT was assumed adequate for complete voice recovery in symptomatic VCP. Vocal cord medialization under general anesthesia was performed for permanent VCP 12 months after thyroidectomy.
Base-Case Analysis
Base-case analysis was performed according to the established guideline for cost-effectiveness analysis. 21 The incremental cost-effectiveness ratio (ICER) was the only outcome measurement and equaled (cost of strategy A -cost of strategy B)/(QALY of strategy A -QALY of strategy B). A strategy was considered to be cost-saving if it cost less and was also more effective over the competing strategy-that is, that strategy dominated the competing strategy). A strategy was regarded cost-effective over another strategy if the ICER was less than US$50,000 per QALY gained. This threshold was chosen on the basis of analysis of the cost of current health care resource allocation decisions in the United States. 22 A strategy was regarded as having ''extended dominance'' if it was less effective and had a higher ICER than one of the competing strategies.
Sensitivity Analysis
Univariate sensitivity analysis was performed to evaluate the impact of various outcome probabilities on the basecase analysis. Strategies that had extended dominance in the base-case analysis were eliminated from the sensitivity analysis. Each clinical parameter varied from the lowest to the highest values as suggested in the literature, while other parameters remained constant. Because RLE would cost more than SLE, a negative incremental effectiveness meant SLE was dominant. A threshold analysis was undertaken to capture the threshold clinical values at which the ICER of RLE relative to SLE became zero (cost equivalence favoring the RLE) or less than US$50,000 per QALY gained (RLE was cost-effective relative to SLE). The range of threshold analysis was considerably expanded by adopting the theoretical range from 0 to 100 %. Table 4 shows the results of base-case analysis. After a 2-year period, each patient in RLE spent an extra US$110.20 but gained an additional 0.00036 QALY over SLE-2w. Therefore, the RLE was more costly but also more effective than SLE-2w according to the institution's perspective. However, because the ICER of US$302,755 for RLE relative to SLE-2w was far above the recommended threshold, RLE was not more cost-effective than SLE-2w. RLE was also not cost-effective to the other 2 SLE substrategies because the ICER of RLE relative to SLE-1m and SLE-3m were US$227,883 and US$247,105, respectively. By definition, SLE-1m was regarded as extended dominance because it was less effective than SLE-2w and had a higher ICER ($364,022/QALY vs. $161,994/QALY) than SLE-2w compared with SLE-3m. Therefore, SLE-1m was excluded from subsequent sensitivity analyses. Table 5 shows the univariate sensitivity analysis of RLE versus SLE-2w and SLE-2w versus SLE-3m. Regarding to the comparison between RLE and SLE-2w, RLE remained not cost-effective to SLE-2w when key clinical parameters such as rates of VCP, dysphonia, and permanent ML after IT were varied. Varying these parameters still yielded positive ICER values well above the threshold of 50,000, implying that RLE was not cost-effective. RLE only became cost-saving to SLE-2w if the cost of LE became zero. For the comparison between SLE-2w and SLE-3m, SLE-2w became cost-effective to SLE-3m if rates of permanent VCP increased to 18.6 %, dysphonia either in temporary or permanent VCP at 3 months increased to 80.6 %, or dysphonia without VCP at 3 months increased to 87.0 %. However, because the permanent VCP rate could not rise above the temporary VCP rate, this was excluded from the subsequent threshold analysis. Table 6 shows the threshold analyses of RLE versus SLE-2w and SLE-2w versus SLE-3m. RLE became costeffective to SLE-2w if temporary VCP after total thyroidectomy increased from 7.12 to 42.74 % (i.e., around 6 times) (see Fig. 2 in Appendix). SLE-2w became costeffective to SLE-3m if dysphonia in temporary VCP at 3 months increased [39.13 % (see Fig. 3 in Appendix). Other scenarios included dysphonia in permanent VCP at 3 months increasing [50.29 % and dysphonia without VCP at 3 months increasing [42.69 %.
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DISCUSSION
To our knowledge, ours is the first study to attempt to evaluate whether RLE could be cost-effective relative to three different SLE strategies according to timing of LE. In terms of cost per person, RLE was, unsurprisingly, the most costly strategy compared to the other strategies. Relative to the lowest-cost strategy (SLE-3m), RLE cost 5.8 times more. This was because under the RLE strategy, more patients were subjected to postoperative LE, whereas under the SLE-3m strategy, only those with persistent dysphonia for 3 months were subjected to postoperative LE. In fact, there was a gradual decrease in cost per person as the timing of SLE became delayed (from 2 weeks to 3 months). This was because fewer LE were required over time as the rate of dysphonia decreased over time. In addition, because most VCPs were temporary (i.e., neurapraxia) and tended to recover spontaneously, the actual number of VCP detected and required IT under the SLE3m strategy were among the lowest. In fact, by 2 months, more than 60 % of patients with temporary VCP would have recovered without any treatment or intervention. Although the chance of having more expensive vocal cord medialization in delayed LE might be higher because of delayed diagnosis and treatment of VCP, our data showed that this did not greatly increase the overall cost, as suggested by previous studies. [9] [10] [11] [12] In terms of effectiveness, RLE was also the most effective strategy because all VCP and dysphonia would have been diagnosed and managed within days after thyroidectomy, whereas under the three SLE strategies, there was gradual loss of QOL over time because patients experienced a longer duration of dysphonia and a lower chance of normal voice recovery. However, despite being the most effective strategy according to these arguments, RLE was not cost-effective compared to SLE-2w, SLE-1m, and SLE-3m.
Both the sensitivity and threshold analyses of RLE versus SLE-2w showed that almost none of the reported ranges in clinical parameters affected our conclusion unless the cost of LE was reduced to zero or if temporary VCP increased significantly to 42.7 % (i.e., six times higher than the reported rate). In contrast, the threshold analysis of SLE-2w versus SLE-3m did find three possible scenarios that were within the reported ranges and could potentially make SLE-2w cost-effective compared to SLE-3m. However, they were clinically unlikely: it is unusual to have such a high percentage of postoperative patients complaining of persistent dysphonia 3 months after surgery, regardless of the cause of dysphonia. [23] [24] [25] [26] [27] [28] Therefore, RLE was not cost-effective against the other 3 SLE strategies. Relative to the other two SLE strategies, SLE-3m appears to be a more reasonable and acceptable strategy because of its low cost.
Despite these results, we do acknowledge several limitations of our study. First, our model did not account for potential benefits of self-auditing in RLE (i.e., the surgeon could learn his or her own recurrent laryngeal nerve injury QALY quality-adjusted life-year, ICER incremental cost-effectiveness ratio, VCP vocal cord palsy rates and improve). 1,2 Although this may not affect the present injury rates, it would reduce future injuries, and so in the longer term, RLE may prove cost-effective relative to SLE strategies. Second, some of the assumptions might have been oversimplified. For example, patients with asymptomatic VCP do not necessarily have a normal health state (utility score of 1.0); subtle changes affecting loss of QOL are possible. Also, it is arguable whether every patient with VCP or dysphonia requires immediate IT. Close observation might be more appropriate in mild dysphonia. In actual practice, VCP could be bilateral, and two or three thyroplasties are often required to manage severely symptomatic VCP. [10] [11] [12] In addition, the latter is not necessarily free of complications or discomfort. Nevertheless, most of these would only have increased the ICER of RLE relative to SLE strategies. Also, some of the newer developments (e.g., laryngeal electromyography) in characterizing severity and prognosis of VCP were not included, and despite a comprehensive literature search, selection and publication biases could not be completely ruled out because none of the studies examined were randomized studies.
In conclusion, RLE cannot be recommended on the basis of cost-effectiveness unless the temporary VCP rate increased by six times or the cost of LE was reduced to zero. Regarding the optimal timing of SLE strategies, SLE2w could only become cost-effective to SLE-3m if dysphonia necessitating LE remained very high ([40%) at 3 months. Therefore, according to the institution's perspective, RLE was not cost-effective against the other three SLE strategies. Relative to the other two SLE strategies, SLE-3m appears a more reasonable strategy, given its relative low overall cost. 
